Patents by Inventor Jonathan Ting

Jonathan Ting has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250117442
    Abstract: An online concierge system receives unstructured data describing items offered for purchase by various warehouses. To generate attributes for products from the unstructured data, the online concierge system extracts candidate values for attributes from the unstructured data through natural language processing. One or more users associate a subset candidate values with corresponding attributes, and the online concierge system clusters the remaining candidate values with the candidate values of the subset associated with attributes. One or more users provide input on the accuracy of the generated clusters. The candidate values are applied as labels to items by the online concierge system, which uses the labeled items as training data for an attribute extraction model to predict values for one or more attributes from unstructured data about an item.
    Type: Application
    Filed: December 19, 2024
    Publication date: April 10, 2025
    Inventors: Shih-Ting Lin, Jonathan Newman, Min Xie, Haixun Wang
  • Publication number: 20250041384
    Abstract: Selectively providing voltage-gated sodium channel function sufficient to rescue impaired Nav1.1 function to inhibitory neurons is described. Provided voltage-gated sodium channel function sufficient to rescue impaired Nav1.1 function in inhibitory neurons can be used to treat disorders such as epilepsy, and more particularly, Dravet Syndrome.
    Type: Application
    Filed: October 18, 2024
    Publication date: February 6, 2025
    Applicants: Allen Institute, Seattle Children's Hospital d/b/a Seattle Children's Research Institute
    Inventors: John K. Mich, Edward Sebastian Lein, Jonathan Ting, Boaz P. Levi, Erik Hess, Franck Kalume
  • Publication number: 20250041454
    Abstract: Artificial expression constructs for modulating gene expression in targeted central nervous system cell types are described. The artificial expression constructs can be used to express synthetic genes or modify gene expression in neocortical layer 4 (L4) intratelencephalic (IT) neurons and/or neocortical L5 IT neurons.
    Type: Application
    Filed: December 7, 2022
    Publication date: February 6, 2025
    Applicant: Allen Institute
    Inventors: Edward Sebastian Lein, Boaz P. Levi, Jonathan Ting
  • Patent number: 12210591
    Abstract: An online concierge system receives unstructured data describing items offered for purchase by various warehouses. To generate attributes for products from the unstructured data, the online concierge system extracts candidate values for attributes from the unstructured data through natural language processing. One or more users associate a subset candidate values with corresponding attributes, and the online concierge system clusters the remaining candidate values with the candidate values of the subset associated with attributes. One or more users provide input on the accuracy of the generated clusters. The candidate values are applied as labels to items by the online concierge system, which uses the labeled items as training data for an attribute extraction model to predict values for one or more attributes from unstructured data about an item.
    Type: Grant
    Filed: August 19, 2021
    Date of Patent: January 28, 2025
    Assignee: Maplebear Inc.
    Inventors: Shih-Ting Lin, Jonathan Newman, Min Xie, Haixun Wang
  • Patent number: 12121563
    Abstract: Selectively providing voltage-gated sodium channel function sufficient to rescue impaired Nav1.1 function to inhibitory neurons is described. Provided voltage-gated sodium channel function sufficient to rescue impaired Nav1.1 function in inhibitory neurons can be used to treat disorders such as epilepsy, and more particularly, Dravet Syndrome.
    Type: Grant
    Filed: April 9, 2019
    Date of Patent: October 22, 2024
    Assignees: Allen Institute, Seattle Children's Hospital
    Inventors: John K. Mich, Edward Sebastian Lein, Jonathan Ting, Boaz P. Levi, Erik Hess, Franck Kalume
  • Patent number: 12099845
    Abstract: In an approach, responsibility for reissuing a fetch micro-operation is allocated to a reissue queue subsequent to a cache miss corresponding to a cache and the fetch micro-operation. Responsive to higher level cache returning data to the cache, an issue selection algorithm of the issue queue is overridden to prioritize reissuing the fetch micro-operation.
    Type: Grant
    Filed: June 16, 2022
    Date of Patent: September 24, 2024
    Assignee: International Business Machines Corporation
    Inventors: Jonathan Ting Hsieh, Gregory William Alexander, Aaron Tsai, Yossi Shapira
  • Publication number: 20240254514
    Abstract: Artificial expression constructs for modulating gene expression in targeted central nervous system cell types are described. The artificial expression constructs can be used to express synthetic genes or modify gene expression in GABAergic or glutamatergic neurons within the thalamus. In some cases, the artificial constructs can also be used to express synthetic genes or modify gene expression in neurons within the thalamus as well as a secondary cell type.
    Type: Application
    Filed: May 20, 2022
    Publication date: August 1, 2024
    Applicant: ALLEN INSTITUTE
    Inventors: Tanya Daigle, Edward Sebastian Lein, Boaz P. Levi, John K. Mich, Amanda Mitchell, Bosiljka Tasic, Jonathan Ting, Natalie Weed, Hongkui Zeng
  • Publication number: 20240182923
    Abstract: Artificial expression constructs for modulating gene expression in targeted central nervous system cell types are described. The artificial expression constructs can be used to express synthetic genes or modify gene expression in claustrum neurons including L6 IT Car3 neurons.
    Type: Application
    Filed: March 30, 2022
    Publication date: June 6, 2024
    Applicant: Allen Institute
    Inventors: Tanya Daigle, Lucas T. Graybuck, Adriana Estela Sedeño Cortés, Bosiljka Tasic, Jonathan Ting
  • Patent number: 11963764
    Abstract: A flexible oximeter device for measuring pulse and blood oxygen saturation in tissue includes a first array of first light emitting elements that emit red light, a second array of second light emitting elements that emit green light or near-infrared (NIR) light and an array of sensor elements arranged on at least one flexible substrate. Each sensor element is configured to detect red and green or NIR light, and to output a signal representing an amount of red or green or NIR light detected. The first and second arrays and the array of sensor elements form a plurality of interleaved measurement pixels, each pixel comprising one of the first light emitting elements and a corresponding sensor element, and one of the second light emitting elements and a different corresponding sensor element.
    Type: Grant
    Filed: November 23, 2020
    Date of Patent: April 23, 2024
    Assignee: The Regents of the University of California
    Inventors: Yasser Khan, Donggeon Han, Adrien Pierre, Jonathan Ting, Xingchun Wang, Claire Meyer Lochner, Ana Arias
  • Publication number: 20240117377
    Abstract: Artificial expression constructs for modulating gene expression in GABAergic neurons and astrocytes are described. The artificial expression constructs can be used to express SLC6A1 for the treatment of SLC6A1-associated disorders, among other uses.
    Type: Application
    Filed: February 2, 2022
    Publication date: April 11, 2024
    Applicant: Allen Institute
    Inventors: Bryan Gore, Edward Sebastian Lein, Boaz P. Levi, Deja Machen, Refugio Martinez, John K. Mich, Jonathan Ting
  • Publication number: 20240018543
    Abstract: Artificial expression constructs for modulating gene expression in targeted central nervous system cell types are described. The artificial expression constructs can be used to express synthetic genes or modify gene expression in chandelier cells. Chandelier cells are a subtype of GABAergic interneurons that that have been implicated in disorders such as epilepsy and schizophrenia.
    Type: Application
    Filed: November 10, 2021
    Publication date: January 18, 2024
    Applicant: Allen Institute
    Inventors: Tanya Daigle, Lucas T. Graybuck, Brian Edward Kalmbach, Edward Sebastian Lein, John K. Mich, Boaz P. Levi, Adriana Estela Sedeño Cortés, Bosiljka Tasic, Jonathan Ting, Hongkui Zeng
  • Publication number: 20230409331
    Abstract: In an approach, responsibility for reissuing a fetch micro-operation is allocated to a reissue queue subsequent to a cache miss corresponding to a cache and the fetch micro-operation. Responsive to higher level cache returning data to the cache, an issue selection algorithm of the issue queue is overridden to prioritize reissuing the fetch micro-operation.
    Type: Application
    Filed: June 16, 2022
    Publication date: December 21, 2023
    Inventors: Jonathan Ting Hsieh, Gregory William Alexander, Aaron Tsai, Yossi Shapira
  • Publication number: 20230302158
    Abstract: Artificial expression constructs for modulating gene expression in striatal neurons are described. The artificial expression constructs can be used to express heterologous genes in striatal neurons including in striatal medium spiny neuron-pan, striatal medium spiny neuron-indirect pathway, striatal medium spiny neuron-direct pathway, striatal interneuron-cholinergic, and Drd3+ medium spiny neurons in olfactory tubercle. The artificial expression constructs can be used for many purposes, including to research and treat movement disorders such as Parkinson's disease and Huntington's disease.
    Type: Application
    Filed: August 13, 2021
    Publication date: September 28, 2023
    Applicant: Allen Institute
    Inventors: Tanya Daigle, Edward Sebastian Lein, Boaz P. Levi, John K. Mich, Bosiljka Tasic, Jonathan Ting, Hongkui Zeng
  • Publication number: 20230241166
    Abstract: The present disclosure provides compositions and methods for minimally invasive optogenetic stimulation. More particularly, the present disclosure provides compositions and methods for using an ultra-sensitive step-function opsin for minimally invasive optogenetic stimulation.
    Type: Application
    Filed: April 28, 2021
    Publication date: August 3, 2023
    Applicants: THE BROAD INSTITUTE, INC., MASSACHUSETTS INSTITUTE OF TECHNOLOGY
    Inventors: Guoping Feng, Xin Gong, Jonathan Ting
  • Publication number: 20230212608
    Abstract: Artificial expression constructs for selectively modulating gene expression in selected central nervous system cell types are described. The artificial expression constructs can be used to selectively express synthetic genes or modify gene expression in inhibitory neocortical GABAergic neurons including somatostatin GABAergic neurons, parvalbumin GABAergic neurons, vasointestinal peptide GABAergic neurons, Lamp5 GABAergic neurons, and in some instances astrocytes.
    Type: Application
    Filed: June 4, 2021
    Publication date: July 6, 2023
    Applicant: Allen Institute
    Inventors: Tanya Daigle, Lucas T. Graybuck, Edward Sebastian Lein, Boaz P. Levi, John K. Mich, Adriana Estela Sedeño Cortés, Bosiljka Tasic, Jonathan Ting, Miranda Walker, Hongkui Zeng
  • Publication number: 20230159952
    Abstract: Artificial expression constructs for selectively modulating gene expression in selected central nervous system cell types are described. Particularly, the artificial expression constructs can be used to selectively express synthetic genes and/or modify gene expression in neocortical glutamatergic layer 5 neurons, such as glutamatergic layer 5 extratelencephalic-projecting (L5 ET) neurons.
    Type: Application
    Filed: April 21, 2021
    Publication date: May 25, 2023
    Applicant: ALLEN INSTITUTE
    Inventors: Tanya Daigle, Lucas T. Graybuck, Brian Edward Kalmbach, Edward Sebastian Lein, Boaz P. Levi, John K. Mich, Adriana Estela Sedeño Cortés, Bosiljka Tasic, Jonathan Ting, Hongkui Zeng
  • Publication number: 20230117172
    Abstract: Artificial expression constructs for selectively modulating gene expression in selected central nervous system cell types are described. The artificial expression constructs can be used to selectively express synthetic genes or modify gene expression in astrocytes, oligodendrocytes, microglia, pericytes, SMC, or endothelial cells.
    Type: Application
    Filed: March 26, 2021
    Publication date: April 20, 2023
    Applicant: ALLEN INSTITUTE
    Inventors: Jonathan Ting, Bosiljka Tasic, Boaz P. Levi, Tanya Daigle, Lucas T. Graybuck, Edward Sebastian Lein, John K. Mich, Adriana Estela Sedeño Cortés, Hongkui Zeng
  • Publication number: 20220249703
    Abstract: Artificial expression constructs for selectively modulating gene expression in selected central nervous system cell types are described. The artificial expression constructs can be used to selectively express synthetic genes or modify gene expression in GABAergic neurons generally; and/or GABAergic neuron cell types such as lysosomal associated membrane protein 5 (Lamp5) neurons; vasoactive intestinal polypeptide-expressing (Vip) neurons; somatostatin (Sst) neurons; and/or parvalbumin (Pvalb) neuron cell types. Certain artificial expression constructs additionally drive selective gene expression in Layer 4 and/or layer 5 intratelencephalic (IT) neurons, deep cerebellar nuclear neurons or cerebellar Purkinje cells.
    Type: Application
    Filed: February 14, 2020
    Publication date: August 11, 2022
    Applicant: Allen Institute
    Inventors: Jonathan Ting, Boaz P. Levi, Bosiljka Tasic, John K. Mich, Erik Hess, Edward Sebastian Lein, Lucas T. Graybuck, Tanya Daigle, Hongkui Zeng
  • Publication number: 20210393176
    Abstract: A flexible oximeter device for measuring pulse and blood oxygen saturation in tissue includes a first array of first light emitting elements that emit red light, a second array of second light emitting elements that emit green light or near-infrared (NIR) light and an array of sensor elements arranged on at least one flexible substrate. Each sensor element is configured to detect red and green or NIR light, and to output a signal representing an amount of red or green or NIR light detected. The first and second arrays and the array of sensor elements form a plurality of interleaved measurement pixels, each pixel comprising one of the first light emitting elements and a corresponding sensor element, and one of the second light emitting elements and a different corresponding sensor element.
    Type: Application
    Filed: November 23, 2020
    Publication date: December 23, 2021
    Inventors: Yasser Khan, Donggeon Han, Adrien Pierre, Jonathan Ting, Xingchun Wang, Claire Meyer Lochner, Ana Arias
  • Publication number: 20210395780
    Abstract: Artificial expression constructs for selectively modulating gene expression in selected central nervous system cell types are described. The artificial expression constructs can be used to selectively express synthetic genes or modify gene expression in excitatory cortical neurons, such as primarily within cortical layers 2/3, 4, 5, and 6 and including those with extratelencephalic (ET) projections, intratelencephalic (IT) projections, and pyramidal tract (PT) projections, among others.
    Type: Application
    Filed: November 5, 2019
    Publication date: December 23, 2021
    Applicant: Allen Institute
    Inventors: Lucas T. Graybuck, Bosiljka Tasic, Tanya Daigle, Jonathan Ting, Hongkui Zeng, Brian Edward Kalmbach, John K. Mich, Erik Hess, Edward Sebastian Lein, Boaz P. Levi